Manuel Bañobre

Manuel Bañobre is a Research Scientist and Group Leader at the International Iberian Nanotechnology Laboratory (INL), where he leads the Bañobre Research Group focused on nanomedicine for diagnostic and therapeutic applications in cancer, inflammatory, and neurological diseases. His group works in close collaboration with clinical partners to enable translational medical research and develop personalized treatment approaches.

The Bañobre Group's research spans from fundamental studies on disease biomarkers and cellular interactions to applied cross-disciplinary work on developing nanostructures (inorganic, organic, hybrid) for precision disease diagnosis, therapy, and theranostics. Their work encompasses in vitro (2D, 3D, OoC), ex vivo, and in vivo experimentation across various technology readiness levels within an international framework.

Dr. Bañobre's research interests center on nanomedicine at the frontier of Chemistry, Materials Science, Biophysics, Engineering, and Biology. His group develops innovative approaches for early disease diagnosis and targeted treatment, with particular focus on cancer theranostics, biomarker validation, and translational applications. The interdisciplinary nature of his work enables the development of novel nanoplatforms that bridge fundamental science with clinical needs.

Analysis of Dr. Bañobre's recent publications (2023-2025) reveals a strong focus on magnetic nanoparticles for cancer theranostics, microneedle drug delivery systems, bacteriophage applications, and sustainable nanomaterials for bioimaging. His work demonstrates integration across multiple disciplines, with particular emphasis on translating laboratory findings into clinically relevant applications. Key trends include pH-responsive drug delivery systems, tumor-associated macrophage targeting, and development of novel diagnostic platforms combining nanotechnology with artificial intelligence.

• Carbon-Coated Magnetic Catalysts for environmental applications
• Advanced microneedle systems for healthcare monitoring and drug delivery
• Magnetic nanoparticles for cancer theranostics and environmental remediation
• Bacteriophage delivery systems for food safety and medical applications
• Sustainable fluorescent materials for cancer bioimaging
• Brain-on-a-chip models for neurodegenerative disease screening

Dr. Bañobre mentors numerous PhD students and postdoctoral researchers, fostering the next generation of scientists in nanomedicine. His group includes researchers working on diverse aspects of nanomedicine, from fundamental materials science to clinical applications. The breadth of research projects suggests significant funding support for his interdisciplinary work through initiatives like PROMISEANG, IBEROSmais, UnTAM, CiNTech, HfPT, MAGNOSTICS, CRYSTAL3, BrainChip4MED, and PANA.

The Bañobre Group operates within a collaborative international framework, working at the intersection of multiple scientific disciplines to develop innovative solutions for healthcare challenges. Their laboratory facilities support comprehensive nanomaterials development, characterization, and biological testing across various disease models, positioning them at the forefront of translational nanomedicine research.